Distribution, enrichment mechanisms, and health risk assessment of high-fluorine groundwater in the Yudong Plain, Henan Province, China.

The Yudong Plain is in the eastern part of Henan Province, China, where there is little rain and high evaporation. Compared to other areas in Henan Province, the groundwater fluorine content is generally high, which affects the health of residents. Based on the systematic analysis of water chemistry data of shallow and mid-depth groundwater samples in the Yudong Plain, the causes of shallow and mid-depth high-fluorine groundwater in the Yudong Plain were explored using mathematical statistics, spatial interpolation, and ion ratios. The results show that the fluorine contents of both shallow and mid-depth groundwater in the study area are high. The shallow samples had fluorine contents ranging from 0.1 to 4.89 mg/L, with an exceedance rate of 48% and an average content of 1.15 mg/L. The fluorine content of mid-depth samples ranged from 0.14 to 3.32 mg/L, with an exceedance rate of 68% and an average content of 1.33 mg/L. The shallow high-fluorine groundwater is mainly distributed in the central low-lying area, and its main hydrochemical type is HCO3-Na·Mg; the mid-depth high-fluorine groundwater is mainly distributed in strips in the north and east of the study area, and its main water chemistry type is HCO3-Na. Fluorine enrichment in shallow groundwater in the study area is controlled by rock weathering, evaporation concentration, and competitive adsorption, while leaching and dissolution of fluorine-containing minerals in sedimentary strata are the main factors influencing fluorine enrichment in mid-depth groundwater. The results of the human health risk assessment (HRA) showed that the mean non-carcinogenic hazard quotients (HQs) in shallow groundwater were 0.95, 0.64, 0.57, and 0.55 for infants, children, teenagers, and adults, respectively, while the mean non-carcinogenic HQs in mid-depth groundwater were 1.11, 0.74, 0.66, and 0.63, respectively. The study provides a scientific basis for the rational development and use of groundwater in the area and offers theoretical support for the prevention and control of groundwater pollution.

Oxytocin ameliorates high glucose- and ischemia/reperfusion-induced myocardial injury by suppressing pyroptosis via AMPK signaling pathway.

The present study aimed to explore the role of oxytocin (OT) in myocardial injury induced by ischemia/reperfusion (I/R) and hyperglycemia and its underlying mechanisms. In this study, the isolated rat hearts underwent I/R in Langendorff perfusion model and H9c2 cells were subjected to hypoxia/reoxygenation (H/R) to establish an in vitro model. I/R injury was induced by exposing the rat hearts to 40 min of global ischemia followed by 60 min of reperfusion. H9c2 cells were cultured under the normoglycemic or hyperglycemic condition with or without pretreatment of OT, and then exposed to 4 h of hypoxia and 2 h of reoxygenation. Measurement indicators included myocardial infarct size assessed by triphenyltetrazolium chloride (TTC) staining and hemodynamic parameters in the ex vivo model as well as cell viability detected by cell counting kit 8 (CCK-8), apoptotic rate evaluated by flow cytometry, and the protein expressions by Western blot. The findings demonstrated that OT attenuated myocardial I/R injury. First, OT preconditioning significantly reduced hemodynamic disorders and myocardial infarct sizes. In addition, OT increased cell viability, decreased cell apoptosis and the expressions of IL-18, IL-1ß, cleaved-caspase-1, NLRP3, and GSDMD following H/R. NLRP3 activator nigericin eliminated the beneficial effects of OT in H9c2 cells. Furthermore, OT also activated AMPK and decreased the expressions of pyroptosis-related proteins. Administration of AMPK inhibitor compound C blunted OT-induced AMPK phosphorylation and elevated the expressions of pyroptosis-related proteins in H9c2 cells subjected to H/R with hyperglycemia. OT alleviates myocardial I/R injury with hyperglycemia by inhibiting pyroptosis via AMPK/NLRP3 signaling pathway.

Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3ß/Nrf2 axis.

The present study aimed to investigate whether dexmedetomidine (Dex) exerts cardioprotection effect through inhibiting ferroptosis. Myocardial ischemia/reperfusion injury (MIRI) was induced in Sprague-Dawley rats in Langendorff preparation. The hemodynamic parameters were recorded. Triphenyltetrazolium chloride (TTC) staining was used to determine infarct size. In the in vitro study, the model of hypoxia/reoxygenation (HR) was established in H9c2 cells. Cell viability and apoptosis were detected using cell counting kit 8 (CCK-8), and AV/PI dual staining respectively. Lipid peroxidation as measured by the fluorescence of the fatty acid analog C11-BODIPY581/591 probe and intracellular ferrous iron levels were measured by fluorescence of Phen Green SK (PGSK) probe, whereas immunofluorescence and transmission electron microscopy were also used to examine ferroptosis. Protein levels were investigated by Western blot. The interactions of AMPK/GSK-3ß signaling with Nrf2 were also assessed through AMPK inhibition and GSK-3ß overexpression. Our findings indicated that Dex significantly alleviated myocardial infarction, improved heart function, and decreased HR-induced accumulation of Fe2+ and lipid peroxidation in cardiomyocytes. Dex significantly increased the expression levels of Nrf2, SLC7A11, and GPX4. However, inhibition of Nrf2 by ML385 blunted the protective effect of Dex in HR-treated H9c2 cells. Inhibition of AMPK with a specific inhibitor or siRNA decreased the expression levels of phosphorylation of GSK-3ß and Nrf2 induced by Dex. Overexpression of GSK-3ß resulted in lower levels of nuclear Nrf2, whereas depression of GSK-3ß enhanced expressions of nuclear Nrf2. In conclusion, Dex protects hearts against MIRI-induced ferroptosis via activation of Nrf2 through AMPK/GSK-3ß signaling pathway.